Circulating tumor cell count guidance may improve long-term outcomes for patients with metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainThe use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-

Updated on: January 22,2024

Circulating tumor cell count guidance may improve long-term outcomes for patients with metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainThe use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-

Updated on:January 22,2024

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on: February 18,2024

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on:February 18,2024

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on: December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on:December 28,2023

Familial breast cancer not only inherited genetically, finds new study

by University of MelbourneCredit: CC0 Public DomainMutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic

Updated on: May 21,2024

Familial breast cancer not only inherited genetically, finds new study

by University of MelbourneCredit: CC0 Public DomainMutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic

Updated on:May 21,2024

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on: April 09,2024

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on:April 09,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on: March 09,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on:March 09,2024

In multiple myeloma, different types of blood biopsies match up well with bone marrow tests

by Dana-Farber Cancer InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Bone marrow biopsies are the gold standard

Updated on: April 23,2024

In multiple myeloma, different types of blood biopsies match up well with bone marrow tests

by Dana-Farber Cancer InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Bone marrow biopsies are the gold standard

Updated on:April 23,2024

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on: January 22,2024

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on:January 22,2024

Foreign-born women in U.S. less likely to have mammograms

(HealthDay)—Regardless of the percentage of lifetime spent in the United States, foreign-born women are less likely to ever have received a mammogram compared with U.S.-born women, according to the Oc

Updated on: April 23,2024

Foreign-born women in U.S. less likely to have mammograms

(HealthDay)—Regardless of the percentage of lifetime spent in the United States, foreign-born women are less likely to ever have received a mammogram compared with U.S.-born women, according to the Oc

Updated on:April 23,2024

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on: March 06,2024

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on:March 06,2024

Antibiotics can inhibit skin lymphoma

by University of CopenhagenCredit: University of CopenhagenNew research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibioti

Updated on: March 30,2024

Antibiotics can inhibit skin lymphoma

by University of CopenhagenCredit: University of CopenhagenNew research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibioti

Updated on:March 30,2024